Abstract
Discovering a medication that suitable for all patients is not possible due to the fact that the reaction to medication may differ significantly across different patient subgroups. The heterogeneity of treatment effects is central to the agenda for both personalized medicine and treatment selection. To expedite the development of tailored therapies and improve the treatment efficacy, identification of subgroups that exhibit different treatment effects is thus playing an essential role. In this paper, we consider high-dimensional dense longitudinal observations which have frequent and large number of measurements with high-dimensional covariates. We offer a data-driven subgroup identification method, which incorporates the sparse boosting algorithm into homogeneity pursuit via change point detection. Extensive simulations are carried out to examine the performance of our proposed approach. We further illustrate our method by analyzing a wallaby growth dataset.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.